Valid, reliable, random, and frequent drug testing is an important component of a successful drug court program.
With OpAns' drug testing, which uses our patented DBS collection device, there's no need to worry about staffing urine collections, and you'll get ...
-   A valid specimen from every donor every time
-   Longer detection windows than urine analyzed by federal confirmatory cutoffs
-   Options for remote monitoring of collections (e.g., for home incarcerations)
-   Informed impairment assessments (DUID), from blood levels
Through a sustainable partnership with your Day Report Center or Law Enforcement Office, our expert analytical scientists will analyze your test specimens, report the results faster than the national labs (including into our HIPAA compliant clinic portal), help you understand the test results, and provide expert testimony where required.
We offer an extensive testing menu (including the NIDA-5:cannabinoids, opiates, amphetamines, cocaine, and phencyclidine (PCP)), see our Reference Guides below for details.Coming soon ... our new StikNSpot DBS drug testing methodology is able to expand canabiliod testing beyond the traditional THC carboxilic acid metabolite. We test for THC, the active THC alcohol, and the terminal THC acid metabolite. By measuring THC blood levels we are able to open a windown on the understanding of impairment. Beyond measuring THC our test distinguishes between the delta-8 and -9 forms, clarifying the source of the THC exposure.
We recommend the use of our patented amasse dried bio-fluid specimen (DBS) collection device that was specifically designed for the collection of dried capillary blood that is suitable for QUANTITATIVE analysis, but we do analyze urine specimens as well.
We are inspected regularly by regulatory (HHS) auditors, participate in the appropriate proficiency testing programs, and have excellent inspection and perfomance records.